The cutaneous inflammatory disease remains perhaps the greatest therapeutic challenge in dermatology in terms of prevalence, symptomatic severity and recalcitrance. Atopic dermatitis (AD), nearly 90 years since its first comprehensive description, remains a confused composite of proposed pathomechanisms. This report will examine some of the current hypotheses relating to pathogenesis and possible therapeutic targeting.
|Original language||English (US)|
|Number of pages||3|
|Journal||Allergy: European Journal of Allergy and Clinical Immunology|
|Issue number||SUPPL. 8|
|Publication status||Published - 1988|
ASJC Scopus subject areas